Get the Stockscreener App
3.16
0.32%
-0.010
After Hours:
3.20
0.04
+1.27%
60 Degrees Pharmaceuticals Inc stock is traded at $3.16, with a volume of 65,702.
It is down -0.32% in the last 24 hours and up +62.05% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$3.17
Open:
$3.18
24h Volume:
65,702
Relative Volume:
0.06
Market Cap:
$4.80M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.3169
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
+1.94%
1M Performance:
+62.05%
6M Performance:
-39.23%
1Y Performance:
-79.08%
1-Day Range:
$3.02
$3.2998
1-Week Range:
$2.85
$3.85
52-Week Range:
$1.41
$35.99
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
3.16 | 4.80M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Short Interest Down 43.2% in March - Defense World
Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday? - MSN
60 Degrees Pharma's Breakthrough: New Clinical Trials Target Rising Tick-Borne Disease Crisis - Stock Titan
Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21 - Yahoo Finance
10 Stocks Fall Behind Amid Market Optimism - Insider Monkey
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
60 Degrees Pharmaceuticals’ (SXTP) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
60 Degrees and Yale to progress tafenoquin for babesiosis - Yahoo
60 Degrees Pharmaceuticals (SXTP) Reports 2024 Financial Results - GuruFocus
60 Degrees Pharmaceuticals (SXTP) Announces 1-for-5 Reverse Stoc - GuruFocus
60 Degrees Pharma signs patent agreement with Yale for tick disease medicine development - Mugglehead Magazine
60 Degrees Pharmaceuticals signs Patient License Agreement with Yale - TipRanks
TNF Pharmaceuticals Inc: Navigating Market Fluctuations with a 0.75M Market Cap - investchronicle.com
60 Degrees Pharmaceuticals partners with Yale for drug development By Investing.com - Investing.com South Africa
Traders boost bets Fed will start cutting rates in May - Yahoo Finance
Mr. Yoshida's Brings the Heat with New Spicy Wing & Rib Sauce - Yahoo Finance
InventHelp Inventor Develops New Litter Removal Tool for Poultry Houses (JTK-236) - Yahoo Finance
60 Degrees Pharmaceuticals (SXTP) Stock Rallies On Tafenoquine Patent News - Stocks Telegraph
Will Assurant (AIZ) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Donaldson Exhibits Strong Prospects Despite Persisting Headwinds - Yahoo Finance
US trade rep says Trump tariffs are getting results, but things may be 'challenging' for awhile - Yahoo Finance
US Tariff Revenue Gains Seen as Undercut by Declining Trade - Yahoo Finance
SSL or XOM: Which Is the Better Value Stock Right Now? - Yahoo Finance
RYTM Stock Rises 17% on Meeting Goals in Hypothalamic Obesity Study - Yahoo Finance
Watch live: U.S. Trade Rep. Jamieson Greer testifying before Senate Finance Committee - Yahoo
60 Degrees Pharmaceuticals (SXTP) Teams with Yale for Tafenoquine Development - GuruFocus
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March - Benzinga
60 Degrees Pharmaceuticals Signs Patent License Deal to Develop Tafenoquine for Tick-Borne Disease Treatment - marketscreener.com
Sixty Degrees Pharmaceuticals Announces Patent License Agreement To Advance Development Of Tafenoquine - MarketScreener
60 Degrees Pharmaceuticals: Surge or Slump Ahead? - timothysykes.com
SXTP60 degrees pharmaceuticals, Inc. Latest Stock News & Market Updates - Stock Titan
60 Degrees Pharmaceuticals partners with Yale for drug development - Investing.com
First-Ever Babesiosis Prevention Drug: Yale Partners with Sixty Degrees on Breakthrough Treatment - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Trump’s Tariff Guru Gives His Personal ‘Guarantee’ There Won’t Be a Recession - Yahoo News
These Bond ETFs Are Still Winning Amid Trump Tariff Selloff - Yahoo Finance
Indian fintech Juspay secures $60m in Series D funding - Yahoo Finance
Laurentian Bank shares an update on the progress of its strategic plan - The Globe and Mail
ECB's Stournaras says higher inflation due to tariffs could delay monetary policy normalisation - Yahoo Finance
Influential China Bloggers Post Options to Hit Back at Trump - Yahoo Finance
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment - The Globe and Mail
1 Unstoppable Tariff-Proof Growth Stock to Buy Hand Over Fist During the S&P 500 Correction - The Globe and Mail
Will MasterCard (MA) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R) - ACCESS Newswire
Here's Why Enterprise Products Partners (EPD) is a Strong Value Stock - Yahoo Finance
US stock market today: Stock futures continue to plunge on Monday amid Trump tariffs - Yahoo
Recursion Pharmaceuticals (NasdaqGS:RXRX) Sees 27% Weekly Drop After Leadership Changes - Yahoo Finance
DuPont Introduces Liveo Pharma TPE Ultra-Low Temp Tubing - Yahoo Finance
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024 - Yahoo Finance
VSee Health Highlights: AI-Powered Telehealth Redefining the $787 Billion Digital Healthcare Market - Quantisnow
Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree - Yahoo Finance
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
| XU CHERYL | Director |
Aug 27 '24 |
Buy |
1.70 |
5,000 |
8,500 |
41,078 |
| XU CHERYL | Director |
May 16 '24 |
Option Exercise |
0.22 |
2,000 |
446 |
228,934 |
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):